Common Stock, Shares, Outstanding of Aclaris Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aclaris Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Aclaris Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 120,499,433, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Aclaris Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 120,499,433 +12,649,309 +12% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 108,342,592 +36,925,079 +52% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 108,328,794 +36,995,969 +52% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 108,265,529 +37,017,512 +52% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 107,850,124 +36,955,235 +52% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 71,417,513 +598,559 +0.84% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 71,332,825 +563,123 +0.8% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 71,248,017 +4,041,992 +6% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 70,894,889 +4,206,242 +6.3% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 70,818,954 +4,139,313 +6.2% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 70,769,702 +4,102,122 +6.2% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 67,206,025 +5,468,542 +8.9% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 66,688,647 +5,460,201 +8.9% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 66,679,641 +5,452,891 +8.9% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 66,667,580 +5,462,593 +8.9% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 61,737,483 +9,655,754 +19% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 61,228,446 +16,119,132 +36% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 61,226,750 +18,310,363 +43% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 61,204,987 +18,513,873 +43% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 52,081,729 +10,249,509 +25% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 45,109,314 +3,623,676 +8.7% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 42,916,387 +1,535,576 +3.7% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 42,691,114 +1,412,544 +3.4% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 41,832,220 +562,577 +1.4% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 41,485,638 +274,913 +0.67% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 41,380,811 +10,389,751 +34% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 41,278,570 +10,313,274 +33% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 41,269,643 +10,364,014 +34% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 41,210,725 +10,354,220 +34% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 30,991,060 +156,381 +0.51% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 30,965,296 +4,228,779 +16% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 30,905,629 +4,808,511 +18% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 30,856,505 +4,797,324 +18% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 30,834,679 +9,410,684 +44% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 26,736,517 +5,333,512 +25% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 26,097,118 +5,780,195 +28% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 26,059,181 +5,901,678 +29% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 21,423,995 +18,693,568 +685% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 21,403,005 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 20,316,923 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 20,157,503 +17,427,076 +638% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 2,730,427 30 Sep 2015 10-Q 03 Dec 2015 2015 Q3
Q4 2014 2,730,427 31 Dec 2014 10-K 23 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.